2017 BioPacific Conference (19th Annual Conference of CABS) Agenda
Leading the New Wave of Life Sciences Innovation–Technology, Policy, and Investment Trends across the Pacific Rim
| 8:00 AM – 8:30 AM | REGISTRATION |
| Morning Session I: Welcome & Keynote Speeches Session Chair: Yang Tian, PhD, and Carrie Wang, MD |
|
| 8:30 AM – 8:35 AM | Welcome Remarks Alex J. Zhang,PhD, MBA, President-Elect of CABS &Chair of 2017 BioPacific Conference Organizing Committee |
| 8:35 AM – 8:45 AM | A Year of Many Firsts at CABS Cheni Kwok,PhD CLP, President of CABS |
| 8:45 AM – 9:20 AM | Immuno-oncology: What’s next? Thomas Hudson, MD, VP, Head of Oncology Discovery and Early Development, AbbVie |
| 9:20 AM – 9:55 AM | Translating a Trillion Points of Data into Therapies, Diagnostics, and New Insights into Disease Atul Butte,MD, PhD, Director, Institute for Computational Health Sciences and UCSF Distinguished Professor of Pediatrics, University of California, San Francisco |
| 9:55 AM-10:10 AM | BREAK |
| Morning Session II: 2017 CABS K. Fong Award Session Chair: Wentao Zhang, PhD |
|
| 10:10 AM-10:20 AM | CABS K. Fong Award in Life Sciences Presenter: Kenneth Fong,PhD, Chairman, Kenson Ventures Awardee(s): Yingxiang Wang and Edgar Engleman |
| 10:20 AM – 10:35 AM | Award Acceptance Speech (via Video) Yinxiang Wang, PhD, Co-Founder, President, and CSO, Zhejiang Beta Pharmaceuticals |
| 10:35 AM- 11:05 AM | Immunotherapy for Cancer: A Paradigm Shift Edgar Engleman, MD, Managing Partner, Vivo Capital, and Professor of Pathology and of Medicine, Stanford University |
| Morning Session III: Panel Discussion Session Chair:Yan Wang, PhD, and Gavin Lu, PhD |
|
| 11:05 AM-11:20 AM | Diamond Sponsor: Chengdu Medical City Zhao Yang, President of Chengdu Geunion Investment Co., Ltd |
| 11:20 AM – 11:55 PM | IP Considerations in Cross-border Deals between China and US Companies Moderator, Gini Deshpande, PhD, CEO, NuMedii Panelist, Jie Zhou, PhD, JD, Partner, Morrison & Foerster, LLP Panelist, Li Feng, PhD, JD, Partner, Finnegan Panelist, Limin Zheng, PhD, JD, Principal, Fish & Richardson |
| 11:55 AM – 12:15 PM | Platinum Sponsor: Singapore-Sichuan Hi-Tech Innovation Park Zhao Yang, President of Chengdu Geunion Investment Co., Ltd |
| 12:15 PM- 1:00 PM | LUNCH BREAK |
| Afternoon Session I: Keynote Speeches Session Chair: Wenfeng Xu, PhD, Ziyang Zhong, PhD, and Naibo Yang, PhD |
|
| 1:00 PM-1:30 PM | First Principles of Global Leadership David Flores, MBA, Co-founder and CEO, BioCentury |
| 1:30 PM-2:00 PM | Genome Reading and Writing in CNGB Xun Xu, MBA, President, BGI Research Institute |
| 2:00 PM-2:30 PM | Meeting the market needs and creating sustaining value – the LakePharma story HuaTu,PhD, Founder &CEO, LakePharma |
| 2:30 PM-2:45 PM | Sponsor Session:Gold sponsors • Predicine • WuXi AppTec • NamoCell |
| Afternoon Panel Session I: Developing Innovative Therapeutics in China Session Chair: Xiaoli Qin, PhD, and Wei Huang |
|
| 2:45 PM-3:30 PM | Moderator, Cheng Liu, PhD, CEO, Eureka Therapeutics Panelist, Michael An, PhD, Founder and CEO, Curegenix Panelist, Wei Zheng, PhD, Founder and CEO, Suzhou Connect Panelist, Baofu Ni, PhD, Vice President, Kelun Bo-Tai Biopharmaceutical Co. Ltd, and Senior Director of Kelun Pharmaceutical Research Institute Panelist,Tao Huang, PhD, JD, Venture Partner, Cenova Capital |
| 3:30 PM-3:55 PM | COFFEE BREAK |
| Afternoon Session II: Investment and Entrepreneurship Session Chair: Dannis Chang, PharmD, and Shenshen Hu, PhD |
|
| 3:55 PM-4:05 PM | Sponsor Session:Gold sponsors • Genentech • Pharmaron |
| 4:05 PM-4:35 PM | Genomic Medicine and Modern Biotechnology Revolution: My Three Stories Dongliang Ge,PhD, CEO, Apostle, Inc. |
| 4:35 PM-5:30 PM | Afternoon Panel Discussion II:E-Club: Entrepreneurship and Investment Trends in Life Sciences Moderator, Alexis Ji, PhD, MBA, Illumina Ventures Panelist, Vincent Xiang, PhD, MBA, Partner, 6 Dimensions Capital Panelist, Karen Liu, PhD, ManagingPartner, 3E Bioventures Panelist, Julie Papanek, MBA, Partner, Canaan Partners Panelist, Asish Xavier, PhD, MBA, VP, Venture Investments, JNJ Panelist, Lu Zhang, MBA, Associate Director of BD, Ascentage Pharma Panelist, Zhaohui (Johnny) Sun, MS, Co-founder and CIO, Accuragen |
| 5:30 PM | CONFERENCE ADJOURNED |
| 5:30 PM-8:30 PM | Post-Conference Reception Sponsored by Chengdu Medical City(Engage Room and Courtyard) Session Chair: Sihong Zhou and Ken Zhang, PhD |